E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/5/2006 in the Prospect News Biotech Daily.

Aksys warned on Nasdaq Capital Market listing

New York, June 5 - Aksys, Ltd. said it received a letter from Nasdaq warning that it failed to comply with the listing standards for the Nasdaq Capital Market because the value of its listed securities has been below $35 million for the last 10 trading days.

The Lincolnshire, Ill., maker of hemodialysis products and provider of hemodialysis services said it has 30 days to regain compliance.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.